HuagongsheHuagongshe Chemistry Print Report · For research reference only
Methyl morpholine oxide → HCID 67138236, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Methyl morpholine oxide | HCID 82029 | — |
| Reactant | 2-(2,4-Dimethoxy-benzyl)-5-(5-(1-hydroxy-4-methyl-pentyl)-thiophen-2-ylmethyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one | HCID 67138607 | — |
| Catalyst | HCID 178419074 | HCID 178419074 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 67138236 | HCID 67138236 | — |
Reaction Steps
The title C compound, 2-(2,4-dimethoxy-benzyl)-5-[5-(1-hydroxy-4-methyl-pentyl)-thiophen-2-ylmethyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one (125 mg, 0.26 mmol) is dissolved in THF (10 mL) and 4-methylmorpholine N-oxide (152 mg, 1.3 mmol) is added. Tetrapropylammonium perruthenate (TPAP, 9 mg, 0.026 mmol) is added and the mixture is stirred at RT for 1 h. The mixture is filtered through Celite and diluted with EtOAc. The solution is washed with 1N aqueous HCl and the organic layer is dried over anhydrous MgSO4. The solvent is evaporated to afford 2-(2,4-dimethoxy-benzyl)-5-[5-(4-methyl-pentanoyl)-thiophen-2-ylmethyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one as a clear oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07291635B2 |
| Source dataset | uspto-grants-2007_11 |
| ORD ID | ord-31f9f25c7b3849b0a9b6821f0717df2b |
| Source note | uspto-grants-2007_11 |